Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93


Recurrent amplification at 7q21.2 Targets CDK6 gene in primary myxofibrosarcomas and identifies CDK6 overexpression as an independent adverse prognosticator.

Tsai JW, Li CF, Kao YC, Wang JW, Fang FM, Wang YH, Wu WR, Wu LC, Hsing CH, Li SH, Yu SC, Lan J, Huang HY.

Ann Surg Oncol. 2012 Aug;19(8):2716-25. doi: 10.1245/s10434-012-2317-3. Epub 2012 Apr 3.


Prognostic implication of MET overexpression in myxofibrosarcomas: an integrative array comparative genomic hybridization, real-time quantitative PCR, immunoblotting, and immunohistochemical analysis.

Lee JC, Li CF, Fang FM, Wang JW, Jeng YM, Yu SC, Lin YT, Wu JM, Tsai JW, Li SH, Huang HY.

Mod Pathol. 2010 Oct;23(10):1379-92. doi: 10.1038/modpathol.2010.128. Epub 2010 Jul 16.


AMACR amplification in myxofibrosarcomas: a mechanism of overexpression that promotes cell proliferation with therapeutic relevance.

Li CF, Fang FM, Lan J, Wang JW, Kung HJ, Chen LT, Chen TJ, Li SH, Wang YH, Tai HC, Yu SC, Huang HY.

Clin Cancer Res. 2014 Dec 1;20(23):6141-52. doi: 10.1158/1078-0432.CCR-14-1182. Epub 2014 Nov 10.


Prognostic factors of myxofibrosarcomas: implications of margin status, tumor necrosis, and mitotic rate on survival.

Lin CN, Chou SC, Li CF, Tsai KB, Chen WC, Hsiung CY, Yen CF, Huang HY.

J Surg Oncol. 2006 Mar 15;93(4):294-303.


Flow cytometric analysis of DNA ploidy and S-phase fraction in primary localized myxofibrosarcoma: correlations with clinicopathological factors, Skp2 expression, and patient survival.

Huang HY, Huang WW, Wu JM, Huang CK, Wang JW, Eng HL, Lin CN, Chou SC, Yu SC, Fang FM, Lee JC, Li CF.

Ann Surg Oncol. 2008 Aug;15(8):2239-49. doi: 10.1245/s10434-008-9968-0. Epub 2008 May 31.


Early G₁ cyclin-dependent kinases as prognostic markers and potential therapeutic targets in esophageal adenocarcinoma.

Ismail A, Bandla S, Reveiller M, Toia L, Zhou Z, Gooding WE, Kalatskaya I, Stein L, D'Souza M, Litle VR, Peters JH, Pennathur A, Luketich JD, Godfrey TE.

Clin Cancer Res. 2011 Jul 1;17(13):4513-22. doi: 10.1158/1078-0432.CCR-11-0244. Epub 2011 May 18.


Characterization of gene amplification-driven SKP2 overexpression in myxofibrosarcoma: potential implications in tumor progression and therapeutics.

Li CF, Wang JM, Kang HY, Huang CK, Wang JW, Fang FM, Wang YH, Wu WR, Li SH, Yu SC, Lee JC, Lan J, Shiue YL, Wu LC, Huang HY.

Clin Cancer Res. 2012 Mar 15;18(6):1598-610. doi: 10.1158/1078-0432.CCR-11-3077. Epub 2012 Feb 9.


Rsf-1/HBXAP overexpression is independent of gene amplification and is associated with poor outcome in patients with urinary bladder urothelial carcinoma.

Liang PI, Wu LC, Sheu JJ, Wu TF, Shen KH, Wang YH, Wu WR, Shiue YL, Huang HY, Hsu HP, Chen YH, Chen LT, Li CF, Liao AC.

J Clin Pathol. 2012 Sep;65(9):802-7. doi: 10.1136/jclinpath-2012-200897. Epub 2012 Jun 9.


Molecular dissection of the chromosome band 7q21 amplicon in gastroesophageal junction adenocarcinomas identifies cyclin-dependent kinase 6 at both genomic and protein expression levels.

van Dekken H, van Marion R, Vissers KJ, Hop WC, Dinjens WN, Tilanus HW, Wink JC, van Duin M.

Genes Chromosomes Cancer. 2008 Aug;47(8):649-56. doi: 10.1002/gcc.20570.


Heat shock protein 90 overexpression independently predicts inferior disease-free survival with differential expression of the alpha and beta isoforms in gastrointestinal stromal tumors.

Li CF, Huang WW, Wu JM, Yu SC, Hu TH, Uen YH, Tian YF, Lin CN, Lu D, Fang FM, Huang HY.

Clin Cancer Res. 2008 Dec 1;14(23):7822-31. doi: 10.1158/1078-0432.CCR-08-1369.


Genomic and protein expression profiling identifies CDK6 as novel independent prognostic marker in medulloblastoma.

Mendrzyk F, Radlwimmer B, Joos S, Kokocinski F, Benner A, Stange DE, Neben K, Fiegler H, Carter NP, Reifenberger G, Korshunov A, Lichter P.

J Clin Oncol. 2005 Dec 1;23(34):8853-62.


Prognostic implication of ezrin overexpression in myxofibrosarcomas.

Huang HY, Li CF, Fang FM, Tsai JW, Li SH, Lee YT, Wei HM.

Ann Surg Oncol. 2010 Dec;17(12):3212-9. doi: 10.1245/s10434-010-1185-y. Epub 2010 Jun 29.


CKS1B overexpression implicates clinical aggressiveness of hepatocellular carcinomas but not p27(Kip1) protein turnover: an independent prognosticator with potential p27 (Kip1)-independent oncogenic attributes?

Huang CW, Lin CY, Huang HY, Liu HW, Chen YJ, Shih DF, Chen HY, Juan CC, Ker CG, Huang CY, Li CF, Shiue YL.

Ann Surg Oncol. 2010 Mar;17(3):907-22. doi: 10.1245/s10434-009-0779-8. Epub 2009 Oct 29.


Associations of Rsf-1 overexpression with poor therapeutic response and worse survival in patients with nasopharyngeal carcinoma.

Tai HC, Huang HY, Lee SW, Lin CY, Sheu MJ, Chang SL, Wu LC, Shiue YL, Wu WR, Lin CM, Li CF.

J Clin Pathol. 2012 Mar;65(3):248-53. doi: 10.1136/jclinpath-2011-200413. Epub 2011 Nov 12.


Amplification of thymosin beta 10 and AKAP13 genes in metastatic and aggressive papillary thyroid carcinomas.

Fehér LZ, Pocsay G, Krenács L, Zvara A, Bagdi E, Pocsay R, Lukács G, Győry F, Gazdag A, Tarkó E, Puskás LG.

Pathol Oncol Res. 2012 Apr;18(2):449-58. doi: 10.1007/s12253-011-9467-7. Epub 2011 Dec 11.


Cyclin-dependent kinase 4 overexpression is mostly independent of gene amplification and constitutes an independent prognosticator for nasopharyngeal carcinoma.

Chen TJ, Lee SW, Lin LC, Lin CY, Chang KY, Li CF.

Tumour Biol. 2014 Jul;35(7):7209-16. doi: 10.1007/s13277-014-1884-2. Epub 2014 Apr 27.


Skp2 is an independent prognosticator of gallbladder carcinoma among p27(Kip1)-interacting cell cycle regulators: an immunohistochemical study of 62 cases by tissue microarray.

Li SH, Li CF, Sung MT, Eng HL, Hsiung CY, Huang WW, Lin CN, Yu SC, Huang HY.

Mod Pathol. 2007 Apr;20(4):497-507. Epub 2007 Mar 2.


Molecular profile of grade 3 endometrioid endometrial carcinoma: is it a type I or type II endometrial carcinoma?

Alvarez T, Miller E, Duska L, Oliva E.

Am J Surg Pathol. 2012 May;36(5):753-61. doi: 10.1097/PAS.0b013e318247b7bb.

Items per page

Supplemental Content

Write to the Help Desk